Zobrazeno 1 - 10
of 231
pro vyhledávání: '"S, Radowicki"'
Autor:
P. Garnero, Dieter Felsenberg, S. Radowicki, B. Pornel, M.P. Dain, P.D. Delmas, J.A. Stakkestad, P. Hardy, B. Petitier
Publikováno v:
American Journal of Obstetrics and Gynecology. 184:32-40
Objective: A total of 325 of 569 postmenopausal women who were initially recruited into two 2-year, double-blind, placebo-controlled, dose-ranging studies of a matrix transdermal formulation of 17β-estradiol (Menorest) participated in open-label ext
Autor:
S. Radowicki, M. Kunicki
Publikováno v:
Journal of endocrinological investigation. 32(10)
The objective of this study was to evaluate serum prostate specific antigen (PSA) levels in women with menstrual disturbances and fibrocystic mastopathy. A total of 114 women with fibrocystic breast disease with cysts10 mm (group I), 62 with macrocys
Autor:
J, Krzysiek, T, Milewicz, R, Dybkowski, A, Janczak-Saif, A, Dembińska-Kieć, A Z, Anna, I, Guevara, K, Sztefko, S, Radowicki, J S, Dubiel, R, Klimek
Publikováno v:
Przeglad lekarski. 58(5)
Postmenopausal lack of estrogens may accelerate cardiovascular atheromatic changes. Standard exercise test (SET) challenges hidden signs of the vascular involvement. Although the test is known not to carry a risk of thromboembolic complications, it m
Autor:
J, Matuszkiewicz-Rowińska, K, Skórzewska, S, Radowicki, A, Sokalski, S, Niemczyk, K, Wardyn, D, Włodarczyk, J, Przedlacki, J, Puka, M, Switalski, K, Ostrowski
Publikováno v:
Polskie Archiwum Medycyny Wewnetrznej. 102(2)
In 25-30% of premenopausal dialysis women low serum estrogen concentrations are observed. This "premature menopause" can significantly contribute to accelerated bone loss. The aim of the study was to evaluate the effect of estrogen-gestagen replaceme
Autor:
J, Matuszkiewicz-Rowińska, K, Skórzewska, S, Radowicki, A, Sokalski, S, Niemczyk, K, Wardyn, K, Bijak, J, Przedlacki, K, Ostrowski
Publikováno v:
Polskie Archiwum Medycyny Wewnetrznej. 102(2)
It has been reported that postmenopausal women taking hormonal replacement therapy (HRT) are at reduced risk for cardiovascular disease mainly because of favorable changes in serum LDL- and HDL-cholesterol. However, the therapy is also known to incre
Publikováno v:
International Journal of Gynecology & Obstetrics. 107:S624-S625
Publikováno v:
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 9(4)
A total of 277 early postmenopausal women were enrolled in this placebo-controlled 2-year study to examine the efficacy of a matrix transdermal 17beta-estradiol system, at three different dosages (25, 50 and 75 mg/day) combined with sequential oral d
Publikováno v:
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego. 5(28)
In the present study the age-related changes of pQCT values in normal Polish women were examined. The volumetric bone mineral density, trabecular density, cortical density and Strength Strain Index was measured using peripheral quantitative computed
Autor:
S, Radowicki, R, Koczorowski
Publikováno v:
Ginekologia polska. 68(11)
Among 1500 patients in the reproductive age of Clinical Department of Endocrinological Gynecology in State Hospital in Warszawa, Poland estimated the correlations between the onset of benign breast disease (BBD) and the incidence of androgenic syndro
Publikováno v:
Ginekologia polska. 69(2)
A study was undertaken to asses the effects of oral continuous hormone replacement therapy on haemostatic balance. Blood samples were drawn from 28 postmenopausal women (mean age 54.1 +/- 4.1) with severe climacteric complaints. All the women were tr